Stocks News

LAST PRICE
28.2000
TODAY'S CHANGE (%)
Trending Down-0.5300 (-1.8448%)

Bid / Lots
27.9100/ 5
Ask / Lots
29.0000/ 2
Open / Previous Close
28.8100 / 28.7300
Day Range
Low 28.0000
High 28.8100
52 Week Range
Low 24.6100
High 45.5800
Volume
382,925
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- DJ Immunovant Price Target Maintained With a $51.00/Share by HC Wainwright & Co., from 6:27AM ET on Friday Nov 08, 2024 by Dow Jones
  6:27AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: IMVT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IMVT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 06:27 ET (11:27 GMT)
Nov 7, 2024
- CORRECTION:-- Earnings Flash (IMVT) IMMUNOVANT Reports Q2 Loss $-0.74 Per Share, from 9:06AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:06AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: IMVT
  09:06 AM EST, 11/07/2024 (MT Newswires) -- ...
- Immunovant Fiscal Q2 Net Loss Widens, from 8:56AM ET on Thursday Nov 07, 2024 by MT Newswires
  8:56AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: IMVT
  08:56 AM EST, 11/07/2024 (MT Newswires) -- Immunovant (IMVT) reported a fiscal Q2 net loss Thursday of $0.74 per diluted share, widening from a loss of $0.45 a year earlier. Analysts polled by Capital IQ expected a loss of $0.60. The clinical-stage ...
- -- Earnings Flash (IMVT) IMMUNOVANT Reports Q3 Loss $-0.74 Per Share, from 6:38AM ET on Thursday Nov 07, 2024 by MT Newswires
  6:38AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: IMVT
  06:38 AM EST, 11/07/2024 (MT Newswires) -- ...
- Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IMVT
  Total current liabilities 66,653 48,608 Total liabilities 66,653 48,608 Commitments and contingencies Stockholders' equity: Series A preferred stock, par value $0.0001 per share, 10,000 shares authorized, issued and outstanding at September 30, 2024 and March 31, 2024 -- -- Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, no shares issued and outstanding at September 30, 2024 and March 31, 2024 -- -- Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 146,565,049 shares issued and outstanding at September 30, 2024 and 500,000,000 shares authorized, 145,582,999 shares issued and outstanding at March 31, 2024 14 14 Additional paid-in capital 1,469,082 1,441,518 Accumulated other comprehensive income 1,910 1,908 Accumulated deficit (1,021,952) (825,683) --------------- ----------- Total stockholders' equity 449,054 617,757 --------------- ----------- Total liabilities and stockholders' equity $ 515,707 $ 666,365 =============== ===========

Nov 26, 2024
- DJ Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co., from 6:28AM ET on Tuesday Nov 26, 2024 by Dow Jones
  6:28AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: SRRK
Nov 25, 2024
- Sector Update: Health Care Stocks Advance Late Afternoon, from 3:50PM ET on Monday Nov 25, 2024 by MT Newswires
  3:50PM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: SAVA, SRRK, BBIO, TDOC
- Top Midday Gainers, from 1:31PM ET on Monday Nov 25, 2024 by MT Newswires
  1:31PM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: BBWI, SRRK, SKYT
- DJ Scholar Rock Holding Is Maintained at Outperform by Wedbush, from 12:39PM ET on Monday Nov 25, 2024 by Dow Jones
  12:39PM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: SRRK
- DJ Scholar Rock Holding Is Maintained at Buy by Truist Securities, from 11:26AM ET on Monday Nov 25, 2024 by Dow Jones
  11:26AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: SRRK
- Wedbush Raises Price Target on Scholar Rock to $47 From $40, Maintains Outperform Rating, from 9:56AM ET on Monday Nov 25, 2024 by MT Newswires
  9:56AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: SRRK
- Truist Securities Adjusts Price Target on Scholar Rock to $45 From $36, Maintains Buy Rating, from 9:49AM ET on Monday Nov 25, 2024 by MT Newswires
  9:49AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: SRRK
- DJ Rhythm Pharmaceuticals Price Target Maintained With a $69.00/Share by HC Wainwright & Co., from 7:39AM ET on Monday Nov 25, 2024 by Dow Jones
  7:39AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: RYTM
Nov 21, 2024
- DJ ImmunityBio Is Maintained at Buy by D. Boral Capital, from 12:44PM ET on Thursday Nov 21, 2024 by Dow Jones
  12:44PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: IBRX
- ImmunityBio, nCartes Partner on Clinical Trial Data Fulfillment, from 11:15AM ET on Thursday Nov 21, 2024 by MT Newswires
  11:15AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: IBRX

Immunovant Inc
NASDAQ:IMVTUnited States

Search Criteria

Nov 8, 2024

DJ Immunovant Price Target Maintained With a $51.00/Share by HC Wainwright & Co., from 6:27AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

CORRECTION:-- Earnings Flash (IMVT) IMMUNOVANT Reports Q2 Loss $-0.74 Per Share, from 9:06AM ET on Thursday Nov 07, 2024 by MT Newswires

Immunovant Fiscal Q2 Net Loss Widens, from 8:56AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (IMVT) IMMUNOVANT Reports Q3 Loss $-0.74 Per Share, from 6:38AM ET on Thursday Nov 07, 2024 by MT Newswires

Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Nov 26, 2024

DJ Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co., from 6:28AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 25, 2024

Sector Update: Health Care Stocks Advance Late Afternoon, from 3:50PM ET on Monday Nov 25, 2024 by MT Newswires

Top Midday Gainers, from 1:31PM ET on Monday Nov 25, 2024 by MT Newswires

DJ Scholar Rock Holding Is Maintained at Outperform by Wedbush, from 12:39PM ET on Monday Nov 25, 2024 by Dow Jones

DJ Scholar Rock Holding Is Maintained at Buy by Truist Securities, from 11:26AM ET on Monday Nov 25, 2024 by Dow Jones

Wedbush Raises Price Target on Scholar Rock to $47 From $40, Maintains Outperform Rating, from 9:56AM ET on Monday Nov 25, 2024 by MT Newswires

Truist Securities Adjusts Price Target on Scholar Rock to $45 From $36, Maintains Buy Rating, from 9:49AM ET on Monday Nov 25, 2024 by MT Newswires

DJ Rhythm Pharmaceuticals Price Target Maintained With a $69.00/Share by HC Wainwright & Co., from 7:39AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 21, 2024

DJ ImmunityBio Is Maintained at Buy by D. Boral Capital, from 12:44PM ET on Thursday Nov 21, 2024 by Dow Jones

ImmunityBio, nCartes Partner on Clinical Trial Data Fulfillment, from 11:15AM ET on Thursday Nov 21, 2024 by MT Newswires